Tagi
AbbVie, Abbott, Adamed, Aflofarm, Allergan, Amgen, Astellas, AstraZeneca, Bayer, Berlin-Chemie, Berlin-Chemie/Menarini, Biogen, Boehringer Ingelheim, Boston Pharmaceuticals, Bristol-Myers Squibb, Celgene, Diagnosis, Exeltis, Gedeon Richter, GlaxoSmithKline, Hasco-Lek, Janusz Gaudnik, Johnson&Johnson, KRKA, Lek-Am, MSD, Marek Macyszyn, Merck, Mylan, Nepentes, Nestle, Novartis, Novo Nordisk, Oleofarm, Paweł Tomczak, Perrigo, Pfizer, Pierre Fabre, Polfarmex, Polpharma, Reckitt Benckiser, Recordati, Roche, Sandoz, Sanofi, Servier, Shire, Takeda, Teva, US Pharmacia, USP Zdrowie, Unipharm, Valeant, Vertex, Walmark, Zentiva